Vir Biotechnology Stock Income Statements

Vir Biotechnology Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Vir Biotechnology Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30

revenues:
collaboration revenue	-495,000	-70,000	10,413,000	-1,102,000	55,000	-987,000	8,858,000	-4,387,000	-13,779,000	46,574,000	21,609,000	309,145,000	-54,941,000	1,229,656,000	809,463,000	102,398,000	5,333,000
contract revenue	1,526,000	1,864,000	865,000	1,391,000	886,000	52,191,000	744,000	289,000	1,057,000	138,000	180,000	39,998,000	12,254,000	282,000	293,000	315,000	168,653,000	605,000	301,000	188,000	43,522,000	487,000	371,000	237,000
grant revenue	183,000	1,238,000	1,096,000	2,091,000	2,134,000	5,172,000	7,185,000	6,737,000	16,519,000	16,245,000	27,621,000	3,125,000	2,058,000	2,521,000	2,991,000	903,000	3,082,000	1,371,000	1,433,000	1,740,000	719,000	5,231,000	609,000	1,166,000
total revenues	1,214,000	3,032,000	12,374,000	2,380,000	3,075,000	56,376,000	16,787,000	2,639,000	3,797,000	62,957,000
operating expenses:
cost of revenue	11,000		684,000	50,000	52,000	59,000	798,000	38,000	22,000	1,907,000	5,996,000	22,253,000	27,921,000	90,149,000	56,877,000	7,836,000	1,144,000
gross profit											385,600,750	352,304,000	-68,550,000	1,142,310,000	13,790,000	95,780,000	175,924,000
yoy											2696.23%	267.83%	-138.97%
qoq											9.45%	-613.94%	-106.00%	8183.61%	-85.60%	-45.56%
gross margin %
research and development	97,509,000	118,645,000	106,083,000	195,178,000	105,113,000	100,125,000	111,915,000	148,253,000	171,860,000	157,643,000	155,173,000	114,166,000	115,082,000	90,227,000	128,341,000	98,669,000	86,126,000	134,870,000	87,095,000	70,684,000	79,653,000	64,979,000	52,931,000	39,863,000
selling, general and administrative	22,283,000	23,944,000	26,701,000	25,744,000	30,265,000	36,273,000	43,090,000	41,080,000	47,101,000	46,778,000	38,743,000	43,174,000	41,590,000	38,255,000	55,777,000	50,496,000	28,781,000
restructuring, long-lived assets impairment and related charges	-172,000	-10,000	-3,944,000	12,712,000	26,275,000
total operating expenses	119,631,000	142,579,000	129,524,000	233,684,000	161,705,000	136,457,000	155,803,000	189,371,000	218,983,000	206,328,000	199,912,000	179,593,000	184,593,000	218,631,000	240,995,000	157,001,000	116,051,000	160,609,000	110,138,000	89,543,000	96,039,000	77,628,000	64,739,000	49,083,000
income from operations	-118,417,000	-139,547,000	-117,150,000	-231,304,000	-158,630,000	-80,081,000	-139,016,000	-186,732,000	-215,186,000	-143,371,000	-150,502,000	194,964,000	-225,222,000	1,013,828,000	571,752,000	-53,385,000	61,017,000	-158,633,000	-108,404,000	-87,615,000	-29,051,000	-71,910,000	-63,759,000	-47,680,000
yoy	-25.35%	74.26%	-15.73%	23.87%	-26.28%	-44.14%	-7.63%	-195.78%	-4.46%	-114.14%	-126.32%	-465.20%	-469.11%	-739.10%	-627.43%	-39.07%	-310.03%	120.60%	70.02%	83.76%
qoq	-15.14%	19.12%	-49.35%	45.81%	98.09%	-42.39%	-25.55%	-13.22%	50.09%	-4.74%	-177.19%	-186.57%	-122.22%	77.32%	-1171.00%	-187.49%	-138.46%	46.34%	23.73%	201.59%	-59.60%	12.78%	33.72%
operating margin %
other income:
change in fair value of equity investments	-3,382,000	6,382,000	-1,172,000	1,130,000	429,000	-5,915,000	-992,000	-2,707,000	-5,086,000	-13,103,000	8,879,000	-13,590,000	-11,390,000	-95,039,000	-26,023,000	164,072,000
interest income	10,785,000	12,288,000	14,153,000	17,527,000	18,846,000	21,283,000	20,736,000	21,931,000	23,016,000	21,307,000	16,172,000	9,332,000	2,200,000	388,000	167,000	11,000	97,000	164,000	288,000	412,000	825,000	1,755,000	1,947,000	2,012,000
other income	226,000	-72,000	-506,000	-893,000	-535,000	-287,000	-1,485,000	882,000	-367,000	-8,021,000	-26,187,000	27,026,000	691,000	2,730,000	-7,000	64,000	752,000	-10,246,000	2,437,000	2,616,000	-2,895,000	-7,069,000	-1,810,000	-2,659,000
total other income	7,629,000	18,598,000	12,475,000	17,764,000	18,740,000	15,081,000	18,259,000	20,106,000	17,563,000	183,000	-1,136,000	22,768,000	-8,499,000	-91,921,000	-25,863,000	164,147,000	849,000	-10,082,000	2,725,000	3,028,000	-2,070,000	-5,314,000	137,000	-647,000
income before benefit from income taxes	-110,788,000	-120,949,000	-104,675,000	-213,540,000	-139,890,000	-65,000,000	-120,757,000	-166,626,000	-197,623,000	-143,188,000	-151,638,000	217,732,000	-233,721,000	921,907,000	545,889,000	110,762,000	61,866,000	-168,715,000	-105,679,000	-84,587,000	-31,121,000	-77,224,000	-63,622,000	-48,327,000
(benefit from) benefit from income taxes	-170,000		264,750	-177,000		-276,000
net income	-110,958,000	-120,965,000	-104,589,000	-213,717,000	-138,378,000	-65,276,000	-115,973,000	-163,413,000	-194,775,000	-140,956,000	-101,603,000	175,312,000	-76,493,000	518,621,000	525,254,000	110,428,000	61,813,000	-168,911,000	-105,649,000	-84,609,000	-31,167,000	-77,240,000	-63,771,000	-48,314,000
yoy	-19.82%	85.31%	-9.82%	30.78%	-28.95%	-53.69%	14.14%	-193.21%	154.63%	-127.18%	-119.34%	58.76%	-223.75%	-407.04%	-597.17%	-230.52%	-298.33%	118.68%	65.67%	75.12%
qoq	-8.27%	15.66%	-51.06%	54.44%	111.99%	-43.71%	-29.03%	-16.10%	38.18%	38.73%	-157.96%	-329.19%	-114.75%	-1.26%	375.65%	78.65%	-136.60%	59.88%	24.87%	171.47%	-59.65%	21.12%	31.99%
net income margin %
net income per share	-0.8	-0.88	-0.76	-1.56	-1.02	-0.48	-0.86	-1.22	-1.45	-1.06	-0.77	1.32	-0.58	3.93	4.04	0.85	0.48	-1.32	-0.85	-0.67	-0.27	-0.71	5.77	-4.6
weighted-average shares outstanding, basic and diluted	138,447,469	137,468,900		136,653,753	136,233,725	135,280,648												127,742,614	119,159,424	125,810,907	114,980,652	108,387,913	30,349,920	10,500,848
benefit from income taxes		-16,000			1,512,000		4,784,000	3,213,000	2,848,000	2,232,000	50,035,000	-42,420,000	157,228,000	-403,286,000	-20,635,000	-334,000	-53,000	-196,000	-21,000	-22,000	-46,000	-16,000	-149,000	13,000
net income attributable to noncontrolling interest										-56,000
net income attributable to vir			-104,342,750	-213,717,000	-138,378,000	-65,276,000	-115,973,000	-163,413,000	-194,775,000	-140,900,000
license revenue from a related party												22,289,000									22,747,000
weighted-average shares outstanding, basic			136,246,865				134,130,924	134,289,620	134,059,079	133,552,839	132,606,767	132,729,530	132,450,018	132,079,391	129,884,967	130,665,831	130,121,943
weighted-average shares outstanding, diluted			136,246,865				134,130,924	134,289,620	134,059,079	133,552,839	134,810,908	134,963,317	132,450,018	134,535,766	133,437,126	133,854,419	133,789,977
revenue:
total revenue											391,596,750	374,557,000	-40,629,000	1,232,459,000	70,667,000	103,616,000	177,068,000	1,976,000	1,734,000	1,928,000	66,988,000	5,718,000	980,000	1,403,000
general and administrative																		25,739,000	23,043,000	18,859,000	16,386,000	12,649,000	11,808,000	9,220,000

We provide you with 20 years income statements for Vir Biotechnology stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Vir Biotechnology stock. Explore the full financial landscape of Vir Biotechnology stock with our expertly curated income statements.

The information provided in this report about Vir Biotechnology stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.